Results 191 to 200 of about 218,651 (379)

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021)

Journal of Small Animal Practice, EarlyView.
Objectives A variety of treatment options for sinonasal aspergillosis have been described, encompassing non‐invasive and invasive approaches. To describe the clinical outcomes in dogs treated for sinonasal aspergillosis in the United Kingdom. Materials and Methods A multi‐centre retrospective survey was performed involving 23 referral centres in the ...
C. D. Prior, H. Swales, A. Kortum, N. Reed, M. Sharman, D. Kelly, A. Kent, B. Glanemann, K. Clarke, C. Lea, E. Roberts, N. Bommer, L. Rutherford, A. Tamborini, K. Murphy, D. J. Batchelor, S. Calleja, R. Burrow, P. M. Jamieson, C. Piazza, M. Best, I. Calvo Saiz, I. Elgueta, S. J. Fowlie, C. Shales, C. Gil Morales, E. Lopez, S. Borgonovi, M. Keane, J. Kennils, E. Izaguirre, M. Hernandez‐Perello, N. Lau, A. Paul, A. Ridyard, E. Shelton, A. Farges, G. Specchia, L. Espada, S. Spence, A. Hrovat, N. Van den Steen, S. Tappin, T. H. Sparks, F. Allerton   +44 more
wiley   +1 more source

The Effect of Breathing Exercises in Pulmonary Emphysema [PDF]

, 1955
J. D. Sinclair
openalex   +1 more source

Moderate to Severe Obstructive Sleep Apnea Is a Risk Factor for Severe COVID‐19—A Nationwide Cohort Study

Journal of Sleep Research, EarlyView.
ABSTRACT The impact of obstructive sleep apnea (OSA) and positive airway pressure (PAP) treatment on COVID‐19 severity is unclear. In this population‐based, nationwide study using multi‐register data, we aimed to assess if OSA is a risk factor for COVID‐19 severity and how adherence to PAP treatment and clinical characteristics affect the risk. Swedish
Mirjam Ljunggren, Andreas Palm, Magnus Ekström, Josefin Sundh, Ludger Grote, Huiqi Li, Fredrik Nyberg, Össur Ingi Emilsson   +7 more
wiley   +1 more source

STUDIES OF TOTAL PULMONARY CAPACITY AND ITS SUB-DIVISIONS. IV. PRELIMINARY OBSERVATIONS ON CASES OF PULMONARY EMPHYSEMA AND OF PNEUMOCONIOSIS [PDF]

, 1933
Alberto Hurtado, Walter W. Fray, Wm. S. McCann   +2 more
openalex   +1 more source

Mapping Bullous Emphysema With Lung Ultrasound: A Prospective Multicentre Study

Respirology, EarlyView.
ABSTRACT Background and Objectives Lung ultrasound holds high diagnostic performance for pleural diseases, notably pneumothorax. Bullous emphysema is a potential differential diagnosis of pneumothorax on ultrasound, but its precise semiology is poorly known.
Kinan El Husseini, Thomas Flament, Sophie Laroumagne, Damien Basille, Mathilde Le Brun, Elise Noël‐Savina, Philippe Richard, Gilles Mangiapan, Elise Artaud‐Macari   +8 more
wiley   +1 more source

Gene expression profile of human lung in a relatively early stage of COPD with emphysema

International Journal of COPD, 2018
Ina Jeong,1,* Jae-Hyun Lim,2,* Dong Kyu Oh,3 Woo Jin Kim,4 Yeon-Mok Oh3 1Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea; 2Biomedical Informatics Research Center, Division of Biomedical Informatics, Seoul National ...
Jeong I, Lim JH, Oh DK, Kim WJ, Oh YM
doaj  

Further Observations on the Pathology of Pulmonary Emphysema in Chronic Bronchitics [PDF]

, 1959
Brian E. Heard
openalex   +1 more source

Emphysema in Coalworkers [PDF]

BMJ, 1970
openaire   +3 more sources

A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM)

American Journal of Respiratory and Critical Care Medicine, 2017
S. Kemp, D. Slebos, A. Kirk, M. Kornaszewska, K. Carron, L. Ek, G. Broman, G. Hillerdal, H. Mal, C. Pison, A. Briault, N. Downer, K. Darwiche, J. Rao, R. Hübner, Christof Ruwwe-Glosenkamp, V. Trosini-Desert, R. Eberhardt, F. Herth, E. Derom, T. Malfait, P. Shah, J. Garner, N. T. ten Hacken, H. Fallouh, S. Leroy, C. Marquette   +26 more
semanticscholar   +1 more source

Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis

Respirology, EarlyView.
ABSTRACT Background and Objective Idiopathic pulmonary fibrosis is a progressive interstitial lung disease characterised by excessive activation of myofibroblasts. However, currently available antifibrotic drugs exhibit limited efficacy. The dysregulation of redox processes plays a significant role in the pathogenesis of idiopathic pulmonary fibrosis ...
Jie Huang, Nana Liu, Yueyue Jin, Shuangyu Han, Lian Li, Yunze Du, Luqing Wei, Dongsheng Li, Yan Zhang, Yubao Wang, Jau‐Shyong Hong, Wen Ning, Jing Feng   +12 more
wiley   +1 more source